ArticleNPJ science of food2026
Mechanism of Morchella polysaccharide in anti-fatigue: the role of the gut microbiota-metabolite axis in mice.
Article in NPJ science of food, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aims to investigate the anti-fatigue effects of crude Morchella polysaccharide (MP) extracted from the Qinghai-Tibet Plateau region in mice, and to preliminarily explore its potential mechanisms based on the gut microbiota-metabolite axis. Chemical analysis indicates that MP exhibits typical characteristics of crude polysaccharides: it consists of multiple monosaccharides (primarily glucose at 72.33%, along with mannose, galactose, etc) and possesses a broad molecular weight distribution (dispersion index (Mw/Mn) of 30.97). To investigate its material basis, we further isolated and purified the primary water-soluble neutral fraction MP1-1. Structural characterization confirmed MP1-1 as a homogeneous glucan composed solely of glucose units, with a backbone linked via →4)-α-D-Glcp-(1 → 4)-type bonds. A negative control group (NC), a positive control group (PC, Rhodiola glycoside,100 mg/kg), and low-, medium-, and high-dose MP groups (50, 100, 200 mg/kg) were established, with continuous gavage for four weeks. Following the final gavage, a weight-bearing swimming test was conducted to record the time to exhaustion and establish a fatigue model. Subsequently, fatigue-related biochemical indicators, gut microbiota composition, and metabolite changes were assessed. The results indicate that MP intervention is significantly associated with an anti-fatigue phenotype. This may occur through regulating the gut microbiota by enriching beneficial bacteria (such as Lactobacillus and Bifidobacterium) and suppressing harmful bacteria (such as Desulfovibrio and Helicobacter), thereby reshaping the intestinal microbiome. These alterations were associated with changes in the host's metabolic profile, particularly the upregulation of energy metabolism pathways (e.g., β-alanine metabolism, pentose phosphate pathway, glycerolipid metabolism) and the disruption of inflammation- and oxidative stress-related metabolic pathways. Ultimately, the MP intervention group exhibited increased glycogen reserves, enhanced antioxidant capacity (elevated SOD and GSH-Px; reduced MDA), and reduced systemic inflammation (decreased IL-6 and TNF-α; increased IL-10). Collectively, these effects delayed fatigue onset, promoted recovery, and significantly prolonged swimming duration. In summary, this study suggests that the polysaccharide extract from Morchella elata, native to the Qinghai-Tibet Plateau, may exert anti-fatigue effects by regulating the "gut microbiota-metabolite-host physiological phenotype" network, providing preliminary experimental evidence for its application in the functional food sector.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.